Large-scale testing (Phase 3)Ended earlyNCT01633060
What this trial is testing
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 432